Lyterian Therapeutics
Fan Gao has a strong background in bioinformatics and research. They currently hold the position of Senior Principal Scientist at Lyterian Therapeutics, where they started in April 2023. Before that, Fan worked at Caltech as the Bioinformatics Director, managing the Caltech Bioinformatics Resource Center and serving the Caltech community from September 2018 to April 2023. Prior to Caltech, Fan had roles as an Associate Scientist at the Broad Institute from October 2013 to December 2018 and as a Staff bioinformatician and Supervisor of Bioinformatics Core at The Picower Institute for Learning & Memory at MIT from September 2013 to August 2018. Fan also held positions as a Research Associate at the Zilkha Neurogenetic Institute, University of Southern California and as a Joint Research Associate at the USC Broad CIRM STEM CELL CENTER from February 2011 to August 2013. Earlier in their career, Fan worked as a Research Scientist and team leader for cell line development at XBiotech USA Inc. from August 2010 to February 2011, and as a Senior Scientist and production manager for antibody product development at InNexus from May 2008 to July 2010. Fan's research experience started as a Research Fellow at Mayo Clinic, where they worked until May 2008.
Fan Gao earned a PhD in Biomedical Engineering (Biophysics and Computational Biology) from the Mayo Clinic Graduate School of Biomedical Sciences from 2000 to 2005. Prior to that, Fan Gao completed a BS in Chemical Physics at the University of Science and Technology of China from 1995 to 2000. Details about Fan Gao's high school education and any additional degrees or certifications are not provided in the given information. However, Fan Gao did obtain a certification in Machine Learning A-Z: Hands-On Python & R in Data Science from Udemy in October 2017.
This person is not in any offices
Lyterian Therapeutics
1 followers
Lyterian Therapeutics derives its name from the Greek word λυτήριος or lutḗrios, that defines the termination, healing, or end of disease. Disease resolution is coordinated by endogenous and exogenous agents that recruit cells and other effectors to the site of injury. We are inspired to learn from the logic that orchestrates homeostatic equilibria and fosters healing in response to disease. At Lyterian Therapeutics, we are committed to developing medicines for patients in need by co-opting physiologically relevant protein homeostatic mechanisms to regulate genetically validated targets.
Employees
1-10